Navigation Links
Drugs Watchdog Faces A Judicial Review

The NHS drugs watchdog will be facing a judicial review in court for the first time. Eisai and Pfizer have been permitted a legal review// over the health watchdog's refusal to approve drugs to treat Alzheimer's disease.

According to the National Institute for Health and Clinical Excellence (Nice), people who are either in the early or in the later stages of Alzheimer's disease cannot be treated with medicines on the NHS. But Eisai and Pfizer mark such assumptions of Nice as ‘irrational’.

Last year Nice declined an appeal over its pronouncement that sufferers with early or late-stage Alzheimer's should not have access to Aricept (donepezil), Reminyl galantamine) or Exelon (rivastigmine). Ebixa (memantine) can be used in clinical studies for sufferers with moderate to severe conditions of Alzheimer's disease.

Judicial review regarding Aricept has been granted to Eisai, the licence holder of Aricept, and Pfizer, its co-promotion partner. This was announced by the companies. Reminyl and Exelon will also be reviewed. As per the activists, patients in the early stages of Alzheimer's also should have access to these drugs which cost around £2.50 a day.

Neil Hunt, chief executive of the Alzheimer's Society which is also involved in this legal battle feels that denying treatment to people who suffer from this devastating disease in the early stages is cruel and unethical. He also added that their legal team will go on to prove that decision of Nice is fundamentally flawed.
JT
'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... , ... The Santana Telehealth Project was honored with the 2017 ATA Humanitarian ... Association’s annual conference, on April 23 in Orlando, FL. , “I am proud that ... of the poor and underserved in other parts of the world,” said Jonathan Linkous, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... Association’s Outstanding Public Communication of Education Research Award. The award honors scholars exemplary ... communities. It recognizes a scholar who has demonstrated the capacity to deepen the ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... The California ... million in charitable dental services to 1,961 people during the April 22-23 event at ... no charge to Californians who experience barriers to care, CDA Cares educates the public ...
(Date:4/24/2017)... , ... April 24, 2017 , ... The John P. ... technology that allows anyone, anywhere to track their cognitive health, and share results with ... their own brain health on the museum's website. , BrainCheck founder, Dr. David Eagleman, ...
(Date:4/24/2017)... ... , ... My T Chai, a South African company that creates a number ... RevNutrition.com, a popular website specializing in sales of nutritional products. , Chai tea ... Siam. It spread across Asia and Africa quickly, and today recipes vary from region ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... provides evidence that an old drug may provide relief for ... that will be presented at the American Academy of ... , April 22 to 28, 2017. When ... drug levodopa has long been considered the gold standard, improving ... the effects of the medication can partially wear off more ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. ... (NASDAQ: IMMY ) ("Imprimis"), an ophthalmology-focused ... Lens ("Precision Lens"), today announced the signing of ... agreement, Precision Lens will deploy a dedicated sales ... geographies in the U.S., primarily focused in 13 ...
Breaking Medicine Technology: